ClinConnect ClinConnect Logo
Search / Trial NCT06837701

The True Face of the Pyramid; Physical Activity Level and Cardiovascular Risk in Patients With Breast Cancer

Launched by HACETTEPE UNIVERSITY · Feb 15, 2025

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Breast Cancer Cardiovascular Disease Physical Activity

ClinConnect Summary

This clinical trial, titled "The True Face of the Pyramid," is studying how physical activity affects heart health in women who have survived breast cancer. Cardiovascular disease is a leading cause of death, and this study aims to understand if being more physically active can help reduce the risk of heart problems for these survivors. The researchers believe that regular exercise may not only improve overall health but also lower the chance of dying from heart disease, especially since many breast cancer survivors face this risk years after their treatment.

To participate in the trial, women aged 40 to 80 who are at least 15 months post-surgery and 6 months after completing their active treatment for breast cancer can volunteer. Participants should be able to read and understand the study materials and follow along with the tests. However, individuals with certain health issues, such as active infections, neurological diseases, or serious heart problems, cannot join. Those who take part can expect to engage in activities that will help researchers learn more about the impact of physical activity on heart health and overall well-being after breast cancer treatment.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. To be between the ages of 40-80 years,
  • 2. Volunteering to participate in the research,
  • 3. At least 15 months after breast cancer surgery,
  • 4. 6 months after active breast cancer treatment (ie surgery/chemotherapy)
  • 5. Having no problem in reading and/or understanding the scales and being able to cooperate with the tests.
  • Exclusion Criteria:
  • 1. Presence of active infection,
  • 2. Having a neurological disease or other clinical diagnosis that may affect cognitive status,
  • 3. Having musculoskeletal and neurological disease, symptomatic heart disease, previous lung surgery and malignant disease that may affect exercise performance.
  • 4. Presence of unstable hypertension or diabetes mellitus

About Hacettepe University

Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.

Locations

Ankara, State, Turkey

Patients applied

0 patients applied

Trial Officials

Ebru Calik Kutukcu, PhD

Principal Investigator

Hacettepe University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported